{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:03:55Z","timestamp":1789617835097,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":148,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1002\/rth2.12800","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T04:14:51Z","timestamp":1664165691000},"page":"e12800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes"],"prefix":"10.1016","volume":"6","author":[{"given":"Natalie","family":"Mathews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-5840","authenticated-orcid":false,"given":"Fred G.","family":"Pluthero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7671-1405","authenticated-orcid":false,"given":"Margaret L.","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Stain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-1763","authenticated-orcid":false,"given":"Manuel","family":"Carcao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-5010","authenticated-orcid":false,"given":"Victor S.","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-7158","authenticated-orcid":false,"given":"Walter H.A.","family":"Kahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1002\/rth2.12800_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1538-7836.2008.03270.x","article-title":"Break\u2010through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A","volume":"7","author":"Collins","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"suppl 6","key":"10.1002\/rth2.12800_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/rth2.12800_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1994.tb00815.x","article-title":"A longitudinal study of orthopaedic outcomes for severe factor\u2010VIII\u2010deficient haemophiliacs. The Orthopaedic Outcome Study Group","volume":"236","author":"Aledort","year":"1994","journal-title":"J Intern Med"},{"issue":"3","key":"10.1002\/rth2.12800_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2516.2000.00397.x","article-title":"The orthopaedic status of severe haemophiliacs in Spain","volume":"6","author":"Aznar","year":"2000","journal-title":"Haemophilia"},{"issue":"7","key":"10.1002\/rth2.12800_bb0030","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0033-1354426","article-title":"Defining severity of hemophilia: more than factor levels","volume":"39","author":"Pavlova","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1002\/rth2.12800_bb0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1538-7836.2011.04228.x","article-title":"Age at first joint bleed and bleeding severity in boys with severe hemophilia A: Canadian Hemophilia Primary Prophylaxis Study","volume":"9","author":"Hang","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1002\/rth2.12800_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0268-960X(03)00038-9","article-title":"Prophylactic factor replacement in hemophilia","volume":"18","author":"Carcao","year":"2004","journal-title":"Blood Rev"},{"issue":"8","key":"10.1002\/rth2.12800_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/MBC.0000000000000225","article-title":"Rationale for individualizing haemophilia care","volume":"26","author":"S\u00f8rensen","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1002\/rth2.12800_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00003086-198006000-00018","article-title":"A radiologic classification of hemophilic arthropathy","volume":"149","author":"Pettersson","year":"1980","journal-title":"Clin Orthop Relat Res"},{"issue":"13","key":"10.1002\/rth2.12800_bb0055","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-01-528414","article-title":"Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens","volume":"125","author":"Oldenburg","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1002\/rth2.12800_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/rth2.12212","article-title":"Developing a new scoring scheme for the Hemophilia Joint Health Score 2.1","volume":"3","author":"Ribeiro","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1002\/rth2.12800_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/bloodadvances.2019001238","article-title":"MRI predicts 5\u2010year joint bleeding and development of arthropathy on radiographs in hemophilia","volume":"4","author":"Foppen","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"10.1002\/rth2.12800_bb0070","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/S2352-3026(18)30048-6","article-title":"Tailored frequency\u2010escalated primary prophylaxis for severe haemophilia A: results of the 16\u2010year Canadian Hemophilia Prophylaxis Study longitudinal cohort","volume":"5","author":"Feldman","year":"2018","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1002\/rth2.12800_bb0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/rth2.12301","article-title":"Hemophilia prophylaxis adherence and bleeding using a tailored, frequency\u2010escalated approach: The Canadian Hemophilia Primary Prophylaxis Study","volume":"4","author":"Dover","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"10.1002\/rth2.12800_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco\u2010Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1002\/rth2.12800_bb0085","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/jth.12025","article-title":"Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada","volume":"10","author":"Kraft","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1002\/rth2.12800_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/rth2.12094","article-title":"Product type and other environmental risk factors for inhibitor development in severe hemophilia A","volume":"2","author":"Peyvandi","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1002\/rth2.12800_bb0095","series-title":"Inhibitors in Hemophilia: A Primer","author":"Carcao","year":"2018"},{"key":"10.1002\/rth2.12800_bb0100","unstructured":"Lawrence L. The high price of hemophilia. ASH Clinical News Vol. 2021; 2020."},{"issue":"2","key":"10.1002\/rth2.12800_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ijlh.13347","article-title":"Overall hemostasis potential and aPTT\u2010clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype","volume":"43","author":"Milos","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1002\/rth2.12800_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1160\/TH11-11-0811","article-title":"Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A","volume":"108","author":"Antovic","year":"2012","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1002\/rth2.12800_bb0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ijlh.12724","article-title":"Clot waveform analysis: where do we stand in 2017?","volume":"39","author":"Sevenet","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"10.1002\/rth2.12800_bb0120","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood-2012-08-378935","article-title":"Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives","volume":"121","author":"Young","year":"2013","journal-title":"Blood"},{"issue":"suppl 3","key":"10.1002\/rth2.12800_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2516.2008.01737.x","article-title":"New assays for monitoring haemophilia treatment","volume":"14","author":"Shima","year":"2008","journal-title":"Haemophilia"},{"issue":"1","key":"10.1002\/rth2.12800_bb0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.seminhematol.2015.10.001","article-title":"Global assays in hemophilia","volume":"53","author":"Chitlur","year":"2016","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1002\/rth2.12800_bb0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1160\/TH04-10-0706","article-title":"Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B","volume":"93","author":"Dargaud","year":"2005","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1002\/rth2.12800_bb0140","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1613258","article-title":"The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding","volume":"88","author":"Al Dieri","year":"2002","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1002\/rth2.12800_bb0145","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1046\/j.1538-7836.2003.00450.x","article-title":"Monitoring the bioavailability of FEIBA with a thrombin generation assay","volume":"1","author":"Varadi","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1002\/rth2.12800_bb0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000071637","article-title":"Factor VIII inhibitor\u2010bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay","volume":"33","author":"Turecek","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"1","key":"10.1002\/rth2.12800_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/hae.14213","article-title":"Comparison of bypassing agents in patients on emicizumab using global hemostasis assays","volume":"27","author":"Kizilocak","year":"2021","journal-title":"Haemophilia"},{"issue":"6","key":"10.1002\/rth2.12800_bb0160","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/hae.13312","article-title":"The pharmacokinetics and pharmacodynamics of single\u2010dose and multiple\u2010dose recombinant activated factor VII in patients with haemophilia A or B","volume":"23","author":"Fern\u00e1ndez\u2010Bello","year":"2017","journal-title":"Haemophilia"},{"issue":"9","key":"10.1002\/rth2.12800_bb0165","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/bloodadvances.2019000849","article-title":"Laboratory monitoring of hemophilia A treatments: new challenges","volume":"4","author":"Lenting","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1002\/rth2.12800_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"3","key":"10.1002\/rth2.12800_bb0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1538-7836.2003.00075.x","article-title":"Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation","volume":"1","author":"Sorensen","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12800_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619836171","article-title":"Evaluation of global hemostatic assays in response to factor VIII inhibitors","volume":"25","author":"Chen","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"10.1002\/rth2.12800_bb0185","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bjh.16574","article-title":"Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis\u2010treated haemophilia A patients with inhibitors","volume":"190","author":"Furukawa","year":"2020","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1002\/rth2.12800_bb0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2516.2003.00767.x","article-title":"Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia","volume":"9","author":"Ingerslev","year":"2003","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/rth2.12800_bb0195","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jth.14694","article-title":"Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study","volume":"18","author":"Janbain","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1 suppl 1","key":"10.1002\/rth2.12800_bb0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.seminhematol.2003.11.024","article-title":"Thromboelastography and recombinant factor VIIa\u2010hemophilia and beyond","volume":"41","author":"Sorensen","year":"2004","journal-title":"Semin Hematol"},{"issue":"7","key":"10.1002\/rth2.12800_bb0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/MBC.0000000000000493","article-title":"Moderate\u2010intensity exercise improves the thromboelastography coagulation index in children with severe hemophilia A","volume":"27","author":"Li","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1002\/rth2.12800_bb0210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2007.06785.x","article-title":"Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study","volume":"139","author":"Dargaud","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1002\/rth2.12800_bb0215","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1538-7836.2006.01905.x","article-title":"Elimination of contact factor activation improves measurement of platelet\u2010dependent thrombin generation by calibrated automated thrombography at low\u2010concentration tissue factor","volume":"4","author":"Dargaud","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1002\/rth2.12800_bb0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ab.2011.12.036","article-title":"Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation","volume":"422","author":"Foley","year":"2012","journal-title":"Anal Biochem"},{"issue":"11","key":"10.1002\/rth2.12800_bb0225","doi-asserted-by":"crossref","first-page":"814a","DOI":"10.1182\/blood.V104.11.2981.2981","article-title":"Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography","volume":"104","author":"Rivard","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1002\/rth2.12800_bb0230","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/jth.13743","article-title":"Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH","volume":"15","author":"Dargaud","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1002\/rth2.12800_bb0235","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1538-7836.2007.02572.x","article-title":"Clearance mechanisms of von Willebrand factor and factor VIII","volume":"5","author":"Lenting","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1002\/rth2.12800_bb0240","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOH.0000000000000074","article-title":"Global assays of hemostasis","volume":"21","author":"Brummel\u2010Ziedins","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1002\/rth2.12800_bb0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MBC.0b013e3282f4bb47","article-title":"Corn trypsin inhibitor in fluorogenic thrombin\u2010generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters","volume":"19","author":"van Veen","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1002\/rth2.12800_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10739680590925682","article-title":"Interactions of platelets, blood\u2010borne tissue factor, and fibrin during arteriolar thrombus formation in vivo","volume":"12","author":"Sim","year":"2005","journal-title":"Microcirculation"},{"issue":"4","key":"10.1002\/rth2.12800_bb0255","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MBC.0000000000001028","article-title":"Which tests can most effectively indicate the clinical phenotype of paediatric haemophilia patients with prophylaxis?","volume":"32","author":"Ay","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1002\/rth2.12800_bb0260","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/hae.12578","article-title":"Is some better than none: are TEG and TGA profiles different in severe FVIII\u2010deficient patients with inhibitors?","volume":"21","author":"Salinas","year":"2015","journal-title":"Haemophilia"},{"issue":"6","key":"10.1002\/rth2.12800_bb0265","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.thromres.2013.04.004","article-title":"Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics","volume":"131","author":"Tarandovskiy","year":"2013","journal-title":"Thromb Res"},{"issue":"4","key":"10.1002\/rth2.12800_bb0270","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/hae.14282","article-title":"A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen","volume":"27","author":"Kennedy","year":"2021","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/rth2.12800_bb0275","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2105\/AJPH.89.3.391","article-title":"Body mass index, weight change, and incidence of self\u2010reported physician\u2010diagnosed arthritis among women","volume":"89","author":"Sahyoun","year":"1999","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1002\/rth2.12800_bb0280","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hae.14078","article-title":"Biological mechanisms underlying inter\u2010individual variation in factor VIII clearance in haemophilia","volume":"26","author":"Turecek","year":"2020","journal-title":"Haemophilia"},{"issue":"6","key":"10.1002\/rth2.12800_bb0285","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1055\/s-0038-1650409","article-title":"Interleukin\u20101 in haemophilic arthritis","volume":"75","author":"Tagariello","year":"1996","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1002\/rth2.12800_bb0290","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613824","article-title":"Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A","volume":"83","author":"Lee","year":"2000","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1002\/rth2.12800_bb0295","first-page":"467","article-title":"Thrombophilic markers in patients with congenital bleeding disorders","volume":"32","author":"Vezendi","year":"2002","journal-title":"Haematologia (Budap)"},{"issue":"3","key":"10.1002\/rth2.12800_bb0300","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1538-7836.2008.03261.x","article-title":"Soluble thrombomodulin partially corrects the premature lysis defect in FVIII\u2010deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor","volume":"7","author":"Foley","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1002\/rth2.12800_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12552","article-title":"Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low\u2010dose secondary prophylaxis study","volume":"5","author":"Wu","year":"2021","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12800","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12800","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922023597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922023597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:24:06Z","timestamp":1762863846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922023597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2475037922023597"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12800","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis (ISTH)","name":"copyright","label":"Copyright"}],"article-number":"e12800"}}